469 related articles for article (PubMed ID: 19004513)
1. Voyages to the (un)known: adaptive design of bioactive compounds.
Schneider G; Hartenfeller M; Reutlinger M; Tanrikulu Y; Proschak E; Schneider P
Trends Biotechnol; 2009 Jan; 27(1):18-26. PubMed ID: 19004513
[TBL] [Abstract][Full Text] [Related]
2. Concept of combinatorial de novo design of drug-like molecules by particle swarm optimization.
Hartenfeller M; Proschak E; Schüller A; Schneider G
Chem Biol Drug Des; 2008 Jul; 72(1):16-26. PubMed ID: 18564216
[TBL] [Abstract][Full Text] [Related]
3. Identification of hits and lead structure candidates with limited resources by adaptive optimization.
Schüller A; Schneider G
J Chem Inf Model; 2008 Jul; 48(7):1473-91. PubMed ID: 18590273
[TBL] [Abstract][Full Text] [Related]
4. De novo drug design.
Hartenfeller M; Schneider G
Methods Mol Biol; 2011; 672():299-323. PubMed ID: 20838974
[TBL] [Abstract][Full Text] [Related]
5. Adaptive combinatorial design of focused compound libraries.
Schneider G; Schüller A
Methods Mol Biol; 2009; 572():135-47. PubMed ID: 20694689
[TBL] [Abstract][Full Text] [Related]
6. Chemical feature-based pharmacophores and virtual library screening for discovery of new leads.
Langer T; Krovat EM
Curr Opin Drug Discov Devel; 2003 May; 6(3):370-6. PubMed ID: 12833670
[TBL] [Abstract][Full Text] [Related]
7. Optimization of experimental antimitotic agents: classical and combinatorial methods.
Gray NS
Prog Cell Cycle Res; 2003; 5():135-43. PubMed ID: 14593707
[TBL] [Abstract][Full Text] [Related]
8. Descriptor-free molecular discovery in large libraries by adaptive substituent reordering.
McAllister SR; Feng XJ; DiMaggio PA; Floudas CA; Rabinowitz JD; Rabitz H
Bioorg Med Chem Lett; 2008 Nov; 18(22):5967-70. PubMed ID: 18851908
[TBL] [Abstract][Full Text] [Related]
9. Selection criteria for drug-like compounds.
Muegge I
Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
[TBL] [Abstract][Full Text] [Related]
10. pso@autodock: a fast flexible molecular docking program based on Swarm intelligence.
Namasivayam V; Günther R
Chem Biol Drug Des; 2007 Dec; 70(6):475-84. PubMed ID: 17986206
[TBL] [Abstract][Full Text] [Related]
11. Solid-phase strategies for the design and synthesis of heterocyclic molecules of medicinal interest.
Kundu B
Curr Opin Drug Discov Devel; 2003 Nov; 6(6):815-26. PubMed ID: 14758753
[TBL] [Abstract][Full Text] [Related]
12. Informative library design as an efficient strategy to identify and optimize leads: application to cyclin-dependent kinase 2 antagonists.
Bradley EK; Miller JL; Saiah E; Grootenhuis PD
J Med Chem; 2003 Sep; 46(20):4360-4. PubMed ID: 13678414
[TBL] [Abstract][Full Text] [Related]
13. Automated medicinal chemistry.
Koppitz M; Eis K
Drug Discov Today; 2006 Jun; 11(11-12):561-8. PubMed ID: 16713909
[TBL] [Abstract][Full Text] [Related]
14. Pursuing the leadlikeness concept in pharmaceutical research.
Hann MM; Oprea TI
Curr Opin Chem Biol; 2004 Jun; 8(3):255-63. PubMed ID: 15183323
[TBL] [Abstract][Full Text] [Related]
15. Assessment of structural diversity in combinatorial synthesis.
Fergus S; Bender A; Spring DR
Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
[TBL] [Abstract][Full Text] [Related]
16. Multicomponent reactions in solid-phase synthesis.
Banfi L; Guanti G; Riva R; Basso A
Curr Opin Drug Discov Devel; 2007 Nov; 10(6):704-14. PubMed ID: 17987522
[TBL] [Abstract][Full Text] [Related]
17. Chemical library synthesis using convergent approaches.
Beeler AB; Schaus SE; Porco JA
Curr Opin Chem Biol; 2005 Jun; 9(3):277-84. PubMed ID: 15939329
[TBL] [Abstract][Full Text] [Related]
18. Process technologies for purity enhancement of large discovery libraries.
Pottorf RS; Player MR
Curr Opin Drug Discov Devel; 2004 Nov; 7(6):777-83. PubMed ID: 15595438
[TBL] [Abstract][Full Text] [Related]
19. CLEVER: pipeline for designing in silico chemical libraries.
Song CM; Bernardo PH; Chai CL; Tong JC
J Mol Graph Model; 2009 Jan; 27(5):578-83. PubMed ID: 18986817
[TBL] [Abstract][Full Text] [Related]
20. Informatics and modeling challenges in fragment-based drug discovery.
Hubbard RE; Chen I; Davis B
Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
